Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia
Journal of Clinical Endocrinology and Metabolism | Oct 18, 2021
Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
Nutrition, Metabolism & Cardiovascular Diseases | Oct 18, 2021
Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality
Nutrition, Metabolism & Cardiovascular Diseases | Oct 14, 2021
Most read this week